Innoviva launches Nortiva Bio to revive Lyndra's LYNX oral drug delivery platform, starting with a Gates-funded monthly contraceptive targeting human trials in 2027.
A healthcare asset and royalties holding company is bringing a long-acting oral medicine approach back to life, resurrecting a drug delivery platform that had accumulated …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF
Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
A new Westlake-backed biotech takes aim at migraines
Innoviva has revealed the next steps for Langer Lab assets it rescued from Lyndra Therapeutics’ collapse, launching Nortiva Bio…
VANCOUVER, BC / ACCESS Newswire / June 15, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company")…
VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / LIR Life Sciences Corp. (CSE:SKNY)(OTCPK:BBCMF)(Frankfurt:N790, WKN:A41QA9)…
The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.
Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the…
The data showed that del-brax, an “antisense oligonucleotide conjugate” being tested against a muscle-wasting disease, met its…
